I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Markovets, Aleksandra A.
39
results:
Search for persons
X
Format
Online (39)
Mediatypes
Articles (Online) (15)
OpenAccess-fulltext (24)
Sorted by: Year
Sorted by: Relevance
?
1
Mixed responses to targeted therapy driven by chromosomal i..:
Hobor, Sebastijan
;
Al Bakir, Maise
;
Hiley, Crispin T.
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
2
Candidate mechanisms of acquired resistance to first-line o..:
Chmielecki, Juliann
;
Gray, Jhanelle E.
;
Cheng, Ying
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
3
Author Correction: Candidate mechanisms of acquired resista..:
Chmielecki, Juliann
;
Gray, Jhanelle E.
;
Cheng, Ying
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
4
Longitudinal Circulating Tumor DNA Modeling to Predict Dise..:
Johnson, Martin
;
Serra Traynor, Carlos
;
Vishwanathan, Karthick
...
Clinical Pharmacology & Therapeutics. 115 (2023) 2 - p. 349-360 , 2023
Link:
https://doi.org/10.1002/..
?
5
Osimertinib + Savolitinib to Overcome Acquired MET-Mediated..:
Hartmaier, Ryan J
;
Markovets, Aleksandra A
;
Ahn, Myung Ju
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827108/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
6
Candidate mechanisms of acquired resistance to first-line o..:
Chmielecki, Juliann
;
Gray, Jhanelle E
;
Cheng, Ying
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971254/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
7
Author Correction: Candidate mechanisms of acquired resista..:
Juliann Chmielecki
;
Jhanelle E. Gray
;
Ying Cheng
...
https://doi.org/10.1038/s41467-023-38999-0. , 2023
Link:
https://doi.org/10.1038/..
?
8
Candidate mechanisms of acquired resistance to first-line o..:
Juliann Chmielecki
;
Jhanelle E. Gray
;
Ying Cheng
...
https://doi.org/10.1038/s41467-023-35961-y. , 2023
Link:
https://doi.org/10.1038/..
?
9
Osimertinib + Savolitinib to Overcome Acquired MET-Mediated..:
Hartmaier, Ryan J.
;
Markovets, Aleksandra A.
;
Ahn, Myung Ju
...
Cancer Discovery. 13 (2022) 1 - p. 98-113 , 2022
Link:
https://doi.org/10.1158/..
?
10
Molecular landscape of osimertinib resistance in patients a..:
Lim, Sun Min
;
Yang, San-Duk
;
Lim, Sangbin
...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592210791 , 2022
Link:
https://doi.org/10.1177/..
?
11
The landscape of therapeutic vulnerabilities in EGFR inhibi..:
Criscione, Steven W.
;
Martin, Matthew J.
;
Oien, Derek B.
...
npj Precision Oncology. 6 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
12
The landscape of therapeutic vulnerabilities in EGFR inhibi..:
Criscione, Steven W
;
Martin, Matthew J
;
Oien, Derek B
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794691/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
13
Molecular landscape of osimertinib resistance in patients a..:
Lim, Sun Min
;
Yang, San-Duk
;
Lim, Sangbin
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891830/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
14
Molecular landscape of osimertinib resistance in patients a..:
Sun Min Lim
;
San-Duk Yang
;
Sangbin Lim
...
https://doi.org/10.1177/17588359221079125. , 2022
Link:
https://doi.org/10.1177/..
?
15
The landscape of therapeutic vulnerabilities in EGFR inhibi..:
Steven W. Criscione
;
Matthew J. Martin
;
Derek B. Oien
...
https://doi.org/10.1038/s41698-022-00337-w. , 2022
Link:
https://doi.org/10.1038/..
1-15